docetaxel anhydrous has been researched along with firefly luciferin in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (firefly luciferin) | Trials (firefly luciferin) | Recent Studies (post-2010) (firefly luciferin) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 989 | 0 | 308 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackler, S; Bouska, J; Ellis, P; Foster, K; Frost, D; Hickson, J; Klaubert, D; Oleksijew, A; Rodriguez, L; Schlessinger, S; Wang, B | 1 |
1 other study(ies) available for docetaxel anhydrous and firefly luciferin
| Article | Year |
|---|---|
Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Docetaxel; Female; Firefly Luciferin; Humans; Luminescent Agents; Mice; Mice, SCID; Molecular Imaging; Neoplasms; Oligopeptides; Taxoids | 2010 |